Longitudinal Study of Immunity to SARS-CoV2 in Ocrelizumab-treated Multiple Sclerosis Patients Up to 2 Years after COVID-19 Vaccination
Ilya Kister,Ryan Curtin,Amanda L. Piquet,Tyler Borko,Jinglan Pei, Barbara L. Banbury,Tamar E. Bacon,Angie Kim,Michael Tuen,Yogambigai Velmurugu,Samantha Nyovanie,Sean Selva,Marie I. Samanovic,Mark J. Mulligan,Yury Patskovsky,Jessica Priest,Mark Cabatingan,Ryan C. Winger,Michelle Krogsgaard,Gregg J. Silverman ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY（2024）
AI 理解论文
溯源树
样例
